Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
Не применимо
Завершено
NCT03938324
| Заболевание | Sickle Cell Disease, Chronic Kidney Diseases, Systemic Lupus Erythematosus, Childhood Cancer |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | Duke University |
|---|
| Статус | Завершено |
|---|
| Участники | 222 участн. |
|---|
| Вмешательство | PiCASO Intervention Group, Sham Comparator: Attention Control Group |
|---|
| Дата начала | 29.10.2019 |
|---|
| Дата завершения | 19.06.2024 |
|---|
| Публикация результатов | 28.07.2025 |
|---|
Кратко
The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.
Change in Self-management as Measured by the Partners in Health Scale
baseline, 3, 6, 9, and 12 months · score on a scale
| PiCASO Intervention Group | 6.7 ± 0.7 score on a scale |
|---|
| Attention Control Group | 6.5 ± 0.8 score on a scale |
|---|
| PiCASO Intervention Group | 6.8 ± 0.7 score on a scale |
|---|
| Attention Control Group | 6.6 ± 0.8 score on a scale |
|---|
| PiCASO Intervention Group | 6.9 ± 0.8 score on a scale |
|---|
| Attention Control Group | 6.6 ± 0.8 score on a scale |
|---|
Patient Activation as Measured by the Patient Activation Measure (PAM-13)
baseline, 3, 6, 9, and 12 months · score on a scale
| PiCASO Intervention Group | 70.0 ± 8.4 score on a scale |
|---|
| Attention Control Group | 68.8 ± 8.7 score on a scale |
|---|
| PiCASO Intervention Group | 72.4 ± 9.2 score on a scale |
|---|
| Attention Control Group | 70.8 ± 9.6 score on a scale |
|---|
| PiCASO Intervention Group | 74.9 ± 10.0 score on a scale |
|---|
| Attention Control Group | 72.8 ± 10.4 score on a scale |
|---|
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.